Preserved value of bone scintigraphy for the detection of skeletal metastases in prostate cancer patients with low prostate-specific antigen levels: effect of hormonal therapy and poor histologic differentiation.
Caglar
Meltem
M
Hacettepe University Medical Faculty, Department of Nuclear Medicine, Ankara, Turkey. mcaglar@hacettepe.edu.tr
Tuncel
Murat
M
D000368:Aged; D001859:Bone Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000556:secondary*; D006801:Humans; D007867:Leg Bones / Q000000981:diagnostic imaging*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000601:surgery; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013131:Spine / Q000000981:diagnostic imaging*; D013669:Technetium Tc 99m Medronate; D014915:Whole-Body Counting
D019275:Radiopharmaceuticals; D017430:Prostate-Specific Antigen; D013669:Technetium Tc 99m Medronate